Equities analysts predict that Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) will post sales of $14.81 million for the current quarter, according to Zacks. Three analysts have made estimates for Lexicon Pharmaceuticals’ earnings, with the highest sales estimate coming in at $16.14 million and the lowest estimate coming in at $13.23 million. Lexicon Pharmaceuticals posted sales of $12.49 […]
